Molecular Imaging of the Receptor HER2 and the Ligand VEGF as Role Models for the Use of ImmunoPET in Drug Development

Sietske Gaykema; E.G.E. de Vries; Thijs Oude Munnink; Wouter Nagengast; Anton Terwisscha Van Scheltinga; Geke A. P. Hospers; Rudi Dierckx; Adrienne Brouwers; Carolien Schröder; Marjolijn Lub-de Hooge

doi:10.1142/9789814317740_0024

Molecular Imaging of the Receptor HER2 and the Ligand VEGF as Role Models for the Use of ImmunoPET in Drug Development

Sietske Gaykema, E.G.E. de Vries, Thijs Oude Munnink, Wouter Nagengast, Anton Terwisscha Van Scheltinga, Geke A. P. Hospers, Rudi Dierckx, Adrienne Brouwers, Carolien Schröder, Marjolijn Lub-de Hooge

Onderzoeksoutput: Chapter › Academic › peer review

Originele taal-2	English
Titel	Trends on the Role of PET in Drug Development
Redacteuren	Philip H. Elsinga, Aren van Waarde, Anne M. J. Paans, Rudi A. J. O. Dierckx
Hoofdstuk	24
Pagina's	681-690
Aantal pagina's	10
Uitgave	1
DOI's	https://doi.org/10.1142/9789814317740_0024
Status	Published - mrt.-2012

Toegang tot document

10.1142/9789814317740_0024

Handle.net

Permanente koppeling

Citeer dit

Gaykema, S., de Vries, E. G. E., Oude Munnink, T., Nagengast, W., Terwisscha Van Scheltinga, A., Hospers, G. A. P., Dierckx, R., Brouwers, A., Schröder, C., & Lub-de Hooge, M. (2012). Molecular Imaging of the Receptor HER2 and the Ligand VEGF as Role Models for the Use of ImmunoPET in Drug Development. In P. H. Elsinga, A. van Waarde, A. M. J. Paans, & R. A. J. O. Dierckx (editors), Trends on the Role of PET in Drug Development (1 uitgave, blz. 681-690) https://doi.org/10.1142/9789814317740_0024

@inbook{3e8b77076f3f447ca1046fd8b558f877,

title = "Molecular Imaging of the Receptor HER2 and the Ligand VEGF as Role Models for the Use of ImmunoPET in Drug Development",

author = "Sietske Gaykema and {de Vries}, E.G.E. and {Oude Munnink}, Thijs and Wouter Nagengast and {Terwisscha Van Scheltinga}, Anton and Hospers, {Geke A. P.} and Rudi Dierckx and Adrienne Brouwers and Carolien Schr{\"o}der and {Lub-de Hooge}, Marjolijn",

year = "2012",

month = mar,

doi = "10.1142/9789814317740_0024",

language = "English",

isbn = "139789814317733",

pages = "681--690",

editor = "Elsinga, {Philip H.} and {van Waarde}, {Aren } and Paans, {Anne M. J.} and Dierckx, {Rudi A. J. O.}",

booktitle = "Trends on the Role of PET in Drug Development",

edition = "1",

}

Gaykema, S, de Vries, EGE , Oude Munnink, T , Nagengast, W, Terwisscha Van Scheltinga, A, Hospers, GAP , Dierckx, R , Brouwers, A , Schröder, C & Lub-de Hooge, M 2012, Molecular Imaging of the Receptor HER2 and the Ligand VEGF as Role Models for the Use of ImmunoPET in Drug Development. in PH Elsinga, A van Waarde, AMJ Paans & RAJO Dierckx (uitgave), Trends on the Role of PET in Drug Development. 1 edn, blz. 681-690. https://doi.org/10.1142/9789814317740_0024

Molecular Imaging of the Receptor HER2 and the Ligand VEGF as Role Models for the Use of ImmunoPET in Drug Development. / Gaykema, Sietske; de Vries, E.G.E.; Oude Munnink, Thijs et al.
Trends on the Role of PET in Drug Development. uitgave / Philip H. Elsinga; Aren van Waarde; Anne M. J. Paans; Rudi A. J. O. Dierckx. 1. uitgave 2012. blz. 681-690.

Onderzoeksoutput: Chapter › Academic › peer review

TY - CHAP

T1 - Molecular Imaging of the Receptor HER2 and the Ligand VEGF as Role Models for the Use of ImmunoPET in Drug Development

AU - Gaykema, Sietske

AU - de Vries, E.G.E.

AU - Oude Munnink, Thijs

AU - Nagengast, Wouter

AU - Terwisscha Van Scheltinga, Anton

AU - Hospers, Geke A. P.

AU - Dierckx, Rudi

AU - Brouwers, Adrienne

AU - Schröder, Carolien

AU - Lub-de Hooge, Marjolijn

PY - 2012/3

Y1 - 2012/3

U2 - 10.1142/9789814317740_0024

DO - 10.1142/9789814317740_0024

M3 - Chapter

SN - 139789814317733

SP - 681

EP - 690

BT - Trends on the Role of PET in Drug Development

A2 - Elsinga, Philip H.

A2 - van Waarde, Aren

A2 - Paans, Anne M. J.

A2 - Dierckx, Rudi A. J. O.

ER -

Gaykema S, de Vries EGE , Oude Munnink T , Nagengast W, Terwisscha Van Scheltinga A, Hospers GAP et al. Molecular Imaging of the Receptor HER2 and the Ligand VEGF as Role Models for the Use of ImmunoPET in Drug Development. In Elsinga PH, van Waarde A, Paans AMJ, Dierckx RAJO, redacteurs, Trends on the Role of PET in Drug Development. 1 uitgave 2012. blz. 681-690 doi: 10.1142/9789814317740_0024